Diagnos Laboratorium Utama Tbk. vs Mahkota Group Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Mahkota Group Tbk. trades at Rp660 (market cap 2.4T, 2.81M 24h volume). The key difference: Mahkota Group Tbk. is far larger — about 7.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Mahkota Group Tbk. is more actively traded (2.81M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | MGRO | |
|---|---|---|
Market Cap | 316.25B | 2.4T |
Volume | 41.7K | 2.81M |
Lot | 417 | 28.11K |
Turnover | 9.66M | 1.86B |
Average Price | 231.65 | 662.82 |
Value | 9.66M | 1.86B |
Indicative Equilibrium Price | 230 | 660 |
Indicative Equilibrium Volume | 2.4K | 548 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Mahkota Group (the Company) was established based on Deed No. 7 dated January 7, 2011 of Cipto Soenaryo, S.H., Notary in Medan.
Read more on MGRO →